Zaremba Rabourn Amy 4
4 · Ocuphire Pharma, Inc. · Filed Nov 16, 2020
Insider Transaction Report
Form 4
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
- Award
Employee Stock Option (right to buy)
[F1]2020-11-11+75,000→ 75,000 totalExercise: $4.05Exp: 2030-11-11→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]1,562 shares vest each month-end from November 2020 through October 2024.
Signature
/s/ Emily J. Johns, by Power of Attorney|2020-11-16